Tests:Coagulation Screen: Difference between revisions
Tests:Coagulation Screen
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 15: | Line 15: | ||
|- | |- | ||
|Constituent Tests | |Constituent Tests | ||
|APTT | |Activated Partial Thromboplastin Time (APTT) | ||
Fibrinogen | Fibrinogen (FIB) | ||
INR | INR | ||
Thrombin Clotting Time | Thrombin Clotting Time (TCT) | ||
|- | |- | ||
|Synonyms | |Synonyms | ||
|Clotting | |Clotting | ||
Coagulation Profile | Coagulation Profile | ||
Prothrombin Ratio (PR) | Prothrombin Ratio (PR) | ||
| Line 36: | Line 34: | ||
Fibrinogen (FIB) | Fibrinogen (FIB) | ||
|- | |||
|Test Availabilty | |||
|Monday - Sunday, testing routinely available out of hours | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 46: | Line 47: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
|Plasma | |Plasma | ||
|- | |- | ||
| | |Preferred | ||
|2.7 mL Na citrate tube <span style="background: #87cefa "> Blue-Top </span> | |||
|- | |||
|Acceptable | |||
| | | | ||
|- | |- | ||
| | |Unacceptable | ||
| | |Clotted | ||
Over or under filled | |||
Grossly haemolysed | |||
Sample older than 24 hours - 12 hours for APTT | |||
|- | |- | ||
| | |Specimen Transportation | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
|1 mL Paediatric Na citrate <span style="background: #87cefa "> Blue-Top </span> | |1 mL Paediatric Na citrate <span style="background: #87cefa "> Blue-Top </span> | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample Type | |Sample Type | ||
| | |||
|- | |||
|Preferred Volume | |||
| | | | ||
|- | |- | ||
| Line 76: | Line 86: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 104: | Line 114: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" |Please indicate if patient is on anticoagulants so the appropriate reference range is reported. | | colspan="2" |Please indicate if patient is on anticoagulants so the appropriate reference range is reported. | ||
This includes, but is not limited to Warfarin, unfractionated heparin, Dabigatran, and Rivaroxaban. Please give full clinical details including all medication. | This includes, but is not limited to Warfarin, unfractionated heparin, Dabigatran, and Rivaroxaban. | ||
Please give full clinical details including all medication. | |||
|} | |} | ||
Revision as of 08:48, 13 March 2025
Overview | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Department | Haematology | ||||||||
| Test Code | CS | ||||||||
| Constituent Tests | Activated Partial Thromboplastin Time (APTT)
Fibrinogen (FIB) INR Thrombin Clotting Time (TCT) | ||||||||
| Synonyms | Clotting
Coagulation Profile Prothrombin Ratio (PR) Thrombin Clotting Time (TCT) Activated Partial Thromboplastin Time (APTT) Fibrinogen (FIB) | ||||||||
| Test Availabilty | Monday - Sunday, testing routinely available out of hours | ||||||||
| Turnaround Time | 0.5-4 hrs | ||||||||
| Stability – Add test | 24 hours at room temperature (INR, PR FIB, TCT)
12 hours at room temperature (APTT) | ||||||||
Specimen Requirements | |||||||||
| Specimen Type | Plasma | ||||||||
| Preferred | 2.7 mL Na citrate tube Blue-Top | ||||||||
| Acceptable | |||||||||
| Unacceptable | Clotted
Over or under filled Grossly haemolysed Sample older than 24 hours - 12 hours for APTT | ||||||||
| Specimen Transportation | |||||||||
| Paediatric Requirements | 1 mL Paediatric Na citrate Blue-Top | ||||||||
Aliquot Requirements | |||||||||
| Sample Type | |||||||||
| Preferred Volume | |||||||||
| Minimum Volume | |||||||||
| Aliquot Transportation | |||||||||
Clinical Information | |||||||||
| Reference Intervals | Includes Prothrombin ratio, APTT, FIB and TCT.
| ||||||||
| Test Method | Mechanical clot detection performed on Stago Compact Max2 Analyser | ||||||||
| Advanced Notice | Not required | ||||||||
| Patient Preparation | Not required | ||||||||
Comments | |||||||||
| Please indicate if patient is on anticoagulants so the appropriate reference range is reported.
This includes, but is not limited to Warfarin, unfractionated heparin, Dabigatran, and Rivaroxaban. Please give full clinical details including all medication. | |||||||||